These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 19667561)

  • 21. The challenge of antibiotic resistant bacterial pathogens: the medical need, the market and prospects for new antimicrobial agents.
    Payne D; Tomasz A
    Curr Opin Microbiol; 2004 Oct; 7(5):435-8. PubMed ID: 15451496
    [No Abstract]   [Full Text] [Related]  

  • 22. Broad- versus narrow-spectrum antibiotic use: the role of in vitro testing and its correlation with clinical efficacy.
    Mouton Y; Senneville E
    Postgrad Med J; 1992; 68 Suppl 3():S68-72. PubMed ID: 1287621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiological interpretation of antibiotic resistance studies - what are we missing?
    Schwaber MJ; De-Medina T; Carmeli Y
    Nat Rev Microbiol; 2004 Dec; 2(12):979-83. PubMed ID: 15550943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 18 November and beyond: observations on the EU Antibiotic Awareness Day.
    Finch R; Sharland M
    J Antimicrob Chemother; 2009 Apr; 63(4):633-5. PubMed ID: 19223300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Economics of antibiotic resistance.
    Sipahi OR
    Expert Rev Anti Infect Ther; 2008 Aug; 6(4):523-39. PubMed ID: 18662118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The important role of the microbiology laboratory in treating patients with infectious diseases and in controlling hospital infections].
    Furukawa K
    Rinsho Byori; 1999 Jul; 47(7):651-7. PubMed ID: 10442044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic techniques in bloodstream infections: where are we going?
    Stefani S
    Int J Antimicrob Agents; 2009; 34 Suppl 4():S9-12. PubMed ID: 19931822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antimicrobial resistance testing in clinical practice].
    Doi Y
    Nihon Rinsho; 2012 Feb; 70(2):272-5. PubMed ID: 22413531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacterial resistance and the dental professionals' role to halt the problem.
    Al-Haroni M
    J Dent; 2008 Feb; 36(2):95-103. PubMed ID: 18164795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meeting the challenge of antibiotic resistance: The PROTEKT US study.
    Stratton CW
    Postgrad Med; 2002 Sep; 112(3 Suppl):7-11. PubMed ID: 19667589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laboratory practices for reporting bacterial susceptibility tests that affect antibiotic therapy.
    Schifman RB; Pindur A; Bryan JA
    Arch Pathol Lab Med; 1997 Nov; 121(11):1168-70. PubMed ID: 9372743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibiotic susceptibility pattern of Staphylococcus species isolated from telephone receivers.
    Smith SI; Opere B; Goodluck HT; Akindolire OT; Folaranmi A; Odekeye OM; Omonigbehin EA
    Singapore Med J; 2009 Feb; 50(2):208-11. PubMed ID: 19296038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibiotic synergy testing should not be routine for patients with cystic fibrosis who are infected with multiresistant bacterial organisms.
    Aaron SD
    Paediatr Respir Rev; 2007 Sep; 8(3):256-61. PubMed ID: 17868924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Phenotype characterisation of Enterococcus spp. strains isolated from urocultures].
    Berceanu Văduva D; Muntean D; Velimirovici D; Licker M; Ionescu G; Rădulescu M; Adămuţ M; Horhat F; Piluţ M; Berceanu Văduva C; Drăgan S; Rada M; Moldovan R
    Bacteriol Virusol Parazitol Epidemiol; 2007; 52(3-4):111-8. PubMed ID: 19326723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The importance and future of antimicrobial surveillance studies.
    Masterton R
    Clin Infect Dis; 2008 Sep; 47 Suppl 1():S21-31. PubMed ID: 18713046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The microbiology laboratory and the physician.
    Neu HC
    QRB Qual Rev Bull; 1979 Mar; 5(3):27-31. PubMed ID: 121407
    [No Abstract]   [Full Text] [Related]  

  • 37. [The antibiotic and chemotherapeutic resistance of Shigella strains isolated in the Microbiology Laboratory of I.P.S.M.P. Neamţ in 1991-1995].
    Păltineanu R; Sărmăşanu O; Chirilă A
    Bacteriol Virusol Parazitol Epidemiol; 1997; 42(1-2):33-8. PubMed ID: 9235141
    [No Abstract]   [Full Text] [Related]  

  • 38. What's the use of susceptibility testing?
    Greenwood D
    J Chemother; 1997 May; 9 Suppl 1():7-12. PubMed ID: 9248957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Has the era of untreatable infections arrived?
    Livermore DM
    J Antimicrob Chemother; 2009 Sep; 64 Suppl 1():i29-36. PubMed ID: 19675016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial susceptibility testing: are we wasting our time?
    Greenwood D
    Br J Biomed Sci; 1993 Mar; 50(1):31-4. PubMed ID: 8032293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.